中华医学杂志（英文版）2018，Vol.131Issue(22)：2683-2692,10.DOI:10.4103/0366-6999.245157
Efficacy and Safety of Tofacitinib in Chinese Patients with Rheumatoid Arthritis
Efficacy and Safety of Tofacitinib in Chinese Patients with Rheumatoid Arthritis
Zhan-Guo Li 1Lisy Wang 2Joel Kremer 3Qi-Zhe Wu 4Yi Liu 5Hu-Ji Xu 6Zhi-Wei Chen 7Chun-De Bao 8Jie-Ruo Gu 9Dong-Bao Zhao 10Yuan An 1Lie-Ju Hwang11
作者信息
- 1. Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing 100044, China
- 2. Clinician, Pfizer Inc, Groton, CT 06340, USA
- 3. Center for Rheumatology, Albany Medical College, Albany, NY 12208, USA
- 4. Medical, Pfizer Inc, Beijing 100010, China
- 5. Department of Rheumatology and Immunology, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China
- 6. Department of Rheumatology and Immunology, Shanghai Changzheng Hospital, The Second Military Medical University, Shanghai 200003, China
- 7. Department of Rheumatology, First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China
- 8. Department of Rheumatology, Shanghai Renji Hospital, Shanghai 200000, China
- 9. Department of Rheumatology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong 510630, China
- 10. Department of Rheumatology and Immunology, Changhai Hospital of Shanghai, Shanghai 200433, China
- 11. Statistician, Pfizer Inc, New York, NY 10017, USA(at the time of analysis)
- 折叠
摘要
关键词
Clinical Efficacy/Patient-Reported Outcomes/Rheumatoid Arthritis/Safety/TofacitinibKey words
Clinical Efficacy/Patient-Reported Outcomes/Rheumatoid Arthritis/Safety/Tofacitinib引用本文复制引用
Zhan-Guo Li,Lisy Wang,Joel Kremer,Qi-Zhe Wu,Yi Liu,Hu-Ji Xu,Zhi-Wei Chen,Chun-De Bao,Jie-Ruo Gu,Dong-Bao Zhao,Yuan An,Lie-Ju Hwang..Efficacy and Safety of Tofacitinib in Chinese Patients with Rheumatoid Arthritis[J].中华医学杂志（英文版）,2018,131(22):2683-2692,10.基金项目
This study was sponsored by Pfizer Inc. （）
